| Primary information |
|---|
| ID | 11509 |
| Uniprot ID | Q9DGC8 |
| Description | Progonadoliberin-1 precursor (Progonadoliberin I) (Medaka-typegonadotropin-releasing hormone) (mdGnRH) (mfGnRH) [Cleaved into- -Gonadoliberin-1 (Gonadoliberin I) (Luteinizing hormone-releasinghormone I) (LH-RH I) (Gonadotropin-releasing hormone I) (GnRH I)(Luliberin I); GnRH-associated peptide 1 (Gn |
| Organism | Oryzias latipes |
| Txonomy | Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;Actinopterygii; Neopterygii; Teleostei; Euteleostei; Neoteleostei;Acanthomorpha; Acanthopterygii; Percomorpha; Atherinomorpha;Beloniformes; Adrianichthyidae; Oryziinae; Oryzias. |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the GnRH family. |
| Tissue Specificity | Expressed in the cell bodies of a cluster of neurons in the preoptic region |
| Post Translational Modification | NA |
| Function | Stimulates the secretion of gonadotropins |
| Length | 91 |
| Molecular Weight | 10307 |
| Name | Gonadoliberin-1 |
| Sequence | QHWSFGLSPG |
| Sequence map | 10 (22-31) |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | Q76KC7;Q76L92;Q76L93;Q90VY1;Q90W00 |
| Domain | NA |
| Pharmaceutical Use | NA
|